Search

Author/Creator Chekenya, M

1. P14.09 BORTEM-17: A Phase IB/II Single-Arm, Control Non-Randomized, Multicentre, Open Label Clinical Trial for Recurrent Glioblastoma with unmethylated MGMT promoter (NCT03643549). (9th September 2021)

Authors:
Goplen, D; Rahman, M A; Arnesen, V S; Brekke, J; Simonsen, A; Andreas, W; Marienhagen, K; Oltedal, L; Haasz, J; Miletic, H; Solheim, T S; Brandal, P; Lie, S A; Chekenya, M
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 2 (2021)
Page Start:
ii39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search